Idera Pharmaceuticals, Inc. to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO and Investor Conference
Published: Feb 05, 2013
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company developing Toll-like receptor targeted product candidates for the treatment of autoimmune diseases and as vaccine adjuvants, today announced that its management will be presenting at the 15th Annual BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the 15th Annual BIO CEO & Investor Conference will take place February 11-12 at the Waldorf=Astoria in New York City. The presentation will take place on Monday, February 11, 2013 at 3:00 p.m. ET.